Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

The government regards human aging not simply as a natural phenomenon but as a treatable disease, and has officially launched ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...

Life runs on information. In living systems, that information takes two main forms: the genome and the epigenome. The genome stays mostly stable. The epigenome, however, constantly shifts, shaped by ...

Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...